Gilead Sciences (GILD): Spannendes Chartbild – 150-USD-Trigger im Visier!
Vom HIV-Spezialisten zum Onkologie-Powerhouse! Rückblick Seit Anfang des Jahres befand sich die Aktie von Gilead Sciences in einem starken Aufwärtsimpuls, ...
Wednesday, August 5, 2026
Tag: GILD
UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook
Gilead Sciences, Inc. (NASDAQ:GILD) is among the most profitable healthcare stocks to buy. On January 26, UBS lifted the price ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.